Printer Friendly

Relevium's Biocannabix to Acquire 30% Stake in Weedsense.

M2 EQUITYBITES-June 12, 2019-Relevium's Biocannabix to Acquire 30% Stake in Weedsense

(C)2019 M2 COMMUNICATIONS http://www.m2.com

12 June 2019 - Florida, US-based Biocnanabix Health Corp., a wholly owned subsidiary of Canada-based Relevium Technologies Inc., (TSX.V: RLV) (OTCQB: RLLVF) (Frankfurt: 6BX) has executed a letter of intent to acquire 30% ownership in Weedsense Inc., a late stage applicant for standard processing and medical sales license, the company said.

Biocannabix has executed an LOI to invest CDN 1.5m (USD 1.13m) into Weedsense Inc. to obtain an initial 30% interest in the company. In addition to its initial investment, Biocannabix has secured an additional option to acquire 100% of the shares after the grant of the licenses by Health Canada and full construction of the facility, for an additional CDN 3.5m (USD 2.6m) payable in shares of Biocannabix.

The transaction is conditional to the grant of the said licenses by Health Canada, financing and is also subject to the approval to the TSXV Stock Exchange.

Weedsense Inc. is building a wholesale and distribution business in Montreal, Quebec.

The company's business model includes wholesale and bulk products from licensed producers or processors and distributing directly to medical patients through a network of pharmacists or clinics.

Weedsense will also service the recreational market by acting as a distributor to provincially-sanctioned wholesalers such as the Ontario Cannabis Store or Societe Quebecoise du Cannabis.

Biocannabix Health Corp. will entrust Weedsense with the storage, sales and distribution of its endo-medical nutraceuticals and medical food products for the Canadian marketplace including pharmacies and hospitals. Biocannabix mission is to become a leader in providing safe, organically sourced endo-medicinal products for pediatric care into the Canadian market.

Relevium Technologies operates in the health and wellness industry, including legal cannabis, with a primary focus on online distribution.

The principal business of the company is the identification, evaluation, acquisition and operations of brands and businesses in the health and wellness markets and medical cannabis.

BGX E-Health LLC markets dietary supplements, nutraceuticals, sports nutrition and cosmeceuticals primarily through its Bioganix brand portfolio in the US and Europe. Biocannabix Health Corp., based in Montreal, Quebec, is a biopharma nutraceutical company focussed on delivering pediatric endo-medicinal nutraceuticals for cannabinoid therapy.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2019 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2019 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Geographic Code:1CANA
Date:Jun 12, 2019
Words:382
Previous Article:RioCan to Acquire 50% Interest in Yonge Sheppard Centre from KingSett Capital.
Next Article:Prosperity CRE Acquires Kansas City Multifamily Community.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters